Yes, high drug prices are an issue but at least there's some certainty that wholesale cuts in prices through Medicare/Medicade price negotiation are off the table (for the moment?) and the risk-reward equation as determined by market forces will prevail, which will ensure investment in R&D to bring new drugs and generics to market. (No wonder someone ploughed $A10M into MYX late on Friday)
http://www.chicagotribune.com/business/ct-trump-drug-costs-20170202-story.html
http://www.vox.com/policy-and-politics/2017/1/31/14453740/trump-medicare-prescription-drugs
Trump flips on US pharma prices
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.27 |
Change
0.000(0.00%) |
Mkt cap ! $618.4M | |||
| Open | High | Low | Value | Volume |
| $7.27 | $7.43 | $7.23 | $640.8K | 87.69K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 457 | $7.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.28 | 475 | 1 |
View Market Depth
| Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$7.24 |
Change
0.000 ( 0.41 %) |
||||
| Open | High | Low | Volume | ||
| $7.34 | $7.43 | $7.23 | 18585 | ||
| Last updated 15.59pm 07/05/2024 ? | |||||
| MYX (ASX) Chart |